Incyte
INCY
#1204
Rank
โ‚น1.857 T
Marketcap
โ‚น9,296
Share price
-0.26%
Change (1 day)
66.97%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): โ‚น650.47

According to Incyte's latest financial reports the company's current EPS (TTM) is โ‚น698.46. In 2025 the company made an earnings per share (EPS) of โ‚น631.49 an increase over its 2024 EPS that were of โ‚น29.66.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น650.473.01%
2025โ‚น631.492029.03%
2024โ‚น29.66-88.39%
2023โ‚น255.4773.38%
2022โ‚น147.35-64.1%
2021โ‚น410.47-408.63%
2020-โ‚น133.00-166.83%
2019โ‚น199.01300%
2018โ‚น49.75-133.33%
2017-โ‚น149.26-378.57%
2016โ‚น53.582700%
2015โ‚น1.91-106.67%
2014-โ‚น28.70-44.44%
2013-โ‚น51.6750%
2012-โ‚น34.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น671.67-3.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น125.34-82.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,701 286.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,385 98.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น602.78-13.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น12.44-101.78%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น55.49-107.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น80.37-111.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น22.01-103.15%๐Ÿ‡บ๐Ÿ‡ธ USA